Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Low CD46 expression on activated CD4+ T cells predict improved Th1 cell reactivity to calcitriol in majority of patients with allergic eosinophilic asthma and healthy donors

J. Stichova, P. Slanina, Z. Chovancova, J. Baros, M. Litzman, J. Litzman, M. Vlkova

. 2024 ; 5 (-) : 1462579. [pub] 20240924

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25002473

BACKGROUND: Previous research showed that the intracellular complement system, with CD46 as its central molecule, regulates the Th1 response associated with IFN-γ production and transition to a type 1 regulatory response (Tr1) characterized by IL-10 production. This transition can be influenced by a vitamin D (calcitriol), favouring a shift towards Tr1 cells and increased IL-10 production, as described in some autoimmune diseases. OBJECTIVE: It is unknown whether calcitriol modulates CD46-induced Th1 response towards regulatory type 1 T cells (Tr1) in allergic eosinophilic asthma and its value in relation to reducing inflammatory response. METHODS: CD4+ T cells from 58 patients with allergic eosinophilic asthma (AEA) and 49 healthy donors (HDs) were stimulated with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol in vitro for 60 h and analyzed by flow cytometry. IFN-γ and IL-10 levels in cell culture supernatants were measured using ELISA. RESULTS: CD4+ T cells from patients with AEA demonstrated elevated CD46 expression in both the non-activated state and under stimulation conditions with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol. Moreover, CD46 expression in AEA patients fluctuated with the pollen season, showing a significant increase during period of low pollen exposure. Calcitriol further induced CD4+Tr1 cells from in vitro generated CD4+Th1 cells in both HDs and AEA patients. However, in both cohorts were individuals (HDs: 35/49, AEA: 40/58) who responded to calcitriol with a more pronounced regulatory response. The calcitriol-induced regulatory effect manifested by a stronger surface decrease of CD46 on activated CD4+ T cells (by 40% in HDs and by 26% in AEA), accompanied by a significant inhibition of IFN-γ and increased IL-10 production (by 31% in HDs and by 85% in AEA). These individuals were termed as the CD46D group. Contrary to this, calcitriol induced an increase in CD46 expression at the CD4+ T cell surface in a minor group of HDs (14/49), and AEA patients (18/58), who were termed as the CD46I group. In CD46I group, CD4+ T cells produced less IFN-γ in comparison with CD46D group (by 33% in HDs and by 43% in AEA) and were unable to upregulate IL-10 production following stimulation with αCD3/αCD46/IL-2/Calcitriol. CONCLUSION: Our results suggest the potential existence of a key for stratifying individuals suitable for calcitriol treatment in the context of low serum vitamin D levels. After validation in clinical studies, this key could be used as an adjunctive therapy not only for patients with allergic eosinophilic asthma, but also for other diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002473
003      
CZ-PrNML
005      
20250428104131.0
007      
ta
008      
250117e20240924sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/falgy.2024.1462579 $2 doi
035    __
$a (PubMed)39403120
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Stichova, Julie $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
245    10
$a Low CD46 expression on activated CD4+ T cells predict improved Th1 cell reactivity to calcitriol in majority of patients with allergic eosinophilic asthma and healthy donors / $c J. Stichova, P. Slanina, Z. Chovancova, J. Baros, M. Litzman, J. Litzman, M. Vlkova
520    9_
$a BACKGROUND: Previous research showed that the intracellular complement system, with CD46 as its central molecule, regulates the Th1 response associated with IFN-γ production and transition to a type 1 regulatory response (Tr1) characterized by IL-10 production. This transition can be influenced by a vitamin D (calcitriol), favouring a shift towards Tr1 cells and increased IL-10 production, as described in some autoimmune diseases. OBJECTIVE: It is unknown whether calcitriol modulates CD46-induced Th1 response towards regulatory type 1 T cells (Tr1) in allergic eosinophilic asthma and its value in relation to reducing inflammatory response. METHODS: CD4+ T cells from 58 patients with allergic eosinophilic asthma (AEA) and 49 healthy donors (HDs) were stimulated with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol in vitro for 60 h and analyzed by flow cytometry. IFN-γ and IL-10 levels in cell culture supernatants were measured using ELISA. RESULTS: CD4+ T cells from patients with AEA demonstrated elevated CD46 expression in both the non-activated state and under stimulation conditions with αCD3/αCD46/IL-2 or αCD3/αCD46/IL-2/Calcitriol. Moreover, CD46 expression in AEA patients fluctuated with the pollen season, showing a significant increase during period of low pollen exposure. Calcitriol further induced CD4+Tr1 cells from in vitro generated CD4+Th1 cells in both HDs and AEA patients. However, in both cohorts were individuals (HDs: 35/49, AEA: 40/58) who responded to calcitriol with a more pronounced regulatory response. The calcitriol-induced regulatory effect manifested by a stronger surface decrease of CD46 on activated CD4+ T cells (by 40% in HDs and by 26% in AEA), accompanied by a significant inhibition of IFN-γ and increased IL-10 production (by 31% in HDs and by 85% in AEA). These individuals were termed as the CD46D group. Contrary to this, calcitriol induced an increase in CD46 expression at the CD4+ T cell surface in a minor group of HDs (14/49), and AEA patients (18/58), who were termed as the CD46I group. In CD46I group, CD4+ T cells produced less IFN-γ in comparison with CD46D group (by 33% in HDs and by 43% in AEA) and were unable to upregulate IL-10 production following stimulation with αCD3/αCD46/IL-2/Calcitriol. CONCLUSION: Our results suggest the potential existence of a key for stratifying individuals suitable for calcitriol treatment in the context of low serum vitamin D levels. After validation in clinical studies, this key could be used as an adjunctive therapy not only for patients with allergic eosinophilic asthma, but also for other diseases.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slanina, Peter $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia $7 xx0331796
700    1_
$a Chovancova, Zita $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
700    1_
$a Baros, Jan $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
700    1_
$a Litzman, Marek $u Department of Economics, Faculty of Business and Economics, Mendel University, Brno, Czechia
700    1_
$a Litzman, Jiri $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
700    1_
$a Vlkova, Marcela $u Faculty of Medicine, Institute of Clinical Immunology and Allergology, Masaryk University, Brno, Czechia $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital, Brno, Czechia
773    0_
$w MED00209375 $t Frontiers in allergy $x 2673-6101 $g Roč. 5 (20240924), s. 1462579
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39403120 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250428104129 $b ABA008
999    __
$a ok $b bmc $g 2254593 $s 1238476
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 5 $c - $d 1462579 $e 20240924 $i 2673-6101 $m Frontiers in allergy $n Front Allergy $x MED00209375
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...